TARSUS PHARMACEUTICALS INC's ticker is TARS and the CUSIP is 87650L103. A total of 45 filers reported holding TARSUS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,778,102 | +27.9% | 100,062 | +30.0% | 0.00% | – |
| Q2 2023 | $1,390,523 | +287.3% | 76,952 | +169.4% | 0.00% | – |
| Q1 2023 | $359,062 | -56.0% | 28,565 | -48.7% | 0.00% | – |
| Q4 2022 | $816,092 | -56.2% | 55,668 | -48.8% | 0.00% | – |
| Q3 2022 | $1,862,000 | +29.2% | 108,728 | +10.1% | 0.00% | – |
| Q2 2022 | $1,441,000 | +203.4% | 98,710 | +249.3% | 0.00% | – |
| Q1 2022 | $475,000 | -24.8% | 28,256 | +0.5% | 0.00% | – |
| Q4 2021 | $632,000 | +10.7% | 28,103 | +6.1% | 0.00% | – |
| Q3 2021 | $571,000 | -26.7% | 26,480 | -1.5% | 0.00% | – |
| Q2 2021 | $779,000 | -16.6% | 26,880 | -7.3% | 0.00% | – |
| Q1 2021 | $934,000 | – | 28,994 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 1,417,157 | $41,069,000 | 3.79% |
| Vivo Capital, LLC | 2,987,331 | $86,573,000 | 3.75% |
| Cormorant Asset Management, LP | 1,514,269 | $43,884,000 | 1.49% |
| Ghost Tree Capital, LLC | 170,000 | $4,927,000 | 1.35% |
| RTW INVESTMENTS, LP | 2,013,601 | $58,354,000 | 0.88% |
| COWEN AND COMPANY, LLC | 514,289 | $14,904,000 | 0.78% |
| Perceptive Advisors | 2,592,832 | $75,140,000 | 0.49% |
| Altium Capital Management LP | 70,573 | $2,045,000 | 0.47% |
| TimesSquare Capital Management, LLC | 686,705 | $19,901,000 | 0.16% |
| Jefferies Group LLC | 442,993 | $12,837,937 | 0.08% |